Proton Magnetic Resonance Spectroscopy (1H-MRS) has emerged as a pivotal tool in schizophrenia research, affording a non‐invasive window into the in vivo neurochemical landscape. By quantifying ...

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and stability of myelin, suggesting an important impact on neurodegenerative diseases ...

New preclinical research in Neuropsychopharmacology focuses on the unique mechanism and site of action of evenamide as a potential treatment for schizophrenia. Subscribe to our newsletter for the ...

MEXICO CITY, MEXICO, 29 July 2025 -- In a revealing Genomic Press Interview published today in Brain Medicine, Dr. Camilo de la Fuente-Sandoval shares how personal history and scientific passion ...

In the intricate chemical symphony of the brain, glutamate stands as the principal conductor. As the brain's most abundant excitatory neurotransmitter, glutamate facilitates our ability to learn, form ...

Scientists say their new insights into how a key brain protein works could help resolve a long-standing question in molecular ...

Alterations in glutamate levels have been implicated in various psychiatric disorders, including schizophrenia, depression and anxiety, and so measuring ACC glutamate levels can provide valuable ...

Researchers have found that adolescents being bullied by their peers are at greater risk of the early stages of psychotic episodes and in turn experience lower levels of a key neurotransmitter in a ...

MILAN--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the ...